pricing

Events

Partner Content

Joint 23rd Medicines for Europe – 20th IGBA Annual Conferenc...

The Joint 23rd Medicines for Europe – 20th IGBA Annual Conference will unite over 300 experts from the generic and biosimilar sectors to discuss market trends, innovative comm

News

Novo enjoys strong Q1 as Trump price crackdown fails to mate...

Novo Nordisk has shaken off fears of a drug pricing crackdown from president Donald Trump, after it beat profit forecasts in Q1 results.

News

Valeant's Siliq price undercuts rivals to offset black box w...

Siliq will be cheaper than rivals from Novartis and Eli Lilly.

News

J&J's Remicade faces further biosimilar competition in US

FDA approves Samsung Bioepis biosimilar.

News

EU regulators back two more orphan drugs, question of pricin...

Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.

News

Sanofi to repay US government $19.8 million

Costly accounting error for Sanofi.

Joint 23rd Medicines for Europe – 20th IGBA Annual Conferenc...

Novo enjoys strong Q1 as Trump price crackdown fails to mate...

Valeant's Siliq price undercuts rivals to offset black box w...

J&J's Remicade faces further biosimilar competition in US

EU regulators back two more orphan drugs, question of pricin...

Sanofi to repay US government $19.8 million

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

pricing

Editor's Picks